Company Monitoring Page for Bluebird-Bio

latest headlines for company on cafepharma

10 Must-Know Biotech Stock Events to Close Out 2016
TheStreet.com
Fri, 09/9/16 - 09:04 pm
Tags:
biotech, Eli Lilly, solanezumab, Biogen, aducanumab, Kite Pharma, KTE-C19, Bluebird Bio, LentiGlobin, Sarepta Therapeutics, eteplirsen, Ophthotech, Fovista, Bristol-Myers Squibb, Opdvio, Acadia, Nuplazid, Celgene, GED-301, Gilead Sciences, M&A
Bluebird bio adds a key process to pioneering gene therapy as it ramps up a pivotal PhIII
Endpoints
Thu, 09/8/16 - 06:28 pm
Tags:
Bluebird Bio, gene therapy, LentiGlobin
Could Toxicity Issues Topple CAR-T Cancer Therapies?
Motley Fool
Sun, 08/28/16 - 10:09 am
Tags:
CAR-T, clinical trials, Juno Therapeutics, Kite Pharma, Bluebird Bio, Ziopharma Oncology
Juno Throws Down The Multiple Myeloma Gauntlet To Bluebird
Seeking Alpha
Tue, 08/9/16 - 10:54 pm
Tags:
Juno Therapeutics, Multiple Myeloma, Bluebird Bio, CAR-T
Juno strikes deal to join bluebird, Novartis in busy multiple myeloma niche
Fierce Biotech
Sat, 08/6/16 - 01:19 pm
Tags:
Juno Therapeutics, Bluebird Bio, Novartis, Multiple Myeloma, BCMA
Can Bluebird Bio Fly Again?
Seeking Alpha
Wed, 05/18/16 - 11:14 am
Tags:
Bluebird Bio, gene therapy
bluebird bio Inc: Catnapping in Cambridge
Motley Fool
Fri, 05/13/16 - 10:20 am
Tags:
Bluebird Bio, earnings
bluebird bio, Inc. Takes Flight Towards First Approval
Motley Fool
Thu, 04/21/16 - 10:05 am
Tags:
Bluebird Bio, FDA, CCALD, Lenti-D
Why bluebird bio's Stock Jumped 12.9% on Wednesday
Motley Fool
Thu, 04/7/16 - 09:39 am
Tags:
Bluebird Bio
This Could Be the Next Big Pharma Buyout
Motley Fool
Sun, 04/3/16 - 10:56 am
Tags:
Big Pharma, M&A, JNJ, Geron, Acadia, Jazz Pharmaceuticals, Bluebird Bio, Kite Pharma
Bluebird Bio Up As Gene Therapy Scores Against Rare Disease
Investors.com
Sat, 03/5/16 - 09:44 am
Tags:
Bluebird Bio, gene therapy, Lenti-D, cerebral adrenoleukodystrophy
Celgene hitches wagon to Bluebird, doles out $10M as biotech launches 1st CAR-T trial
BioPharma Dive
Sun, 02/21/16 - 11:36 am
Tags:
Celgene, Bluebird Bio, CAR-BMCA, CAR-T
Here's Why Bluebird Bio Turned in a Disappointing 2015
Motley Fool
Sat, 01/9/16 - 10:40 am
Tags:
Bluebird Bio, LentiGlobin BB305
2016 Biotech Stock Prediction: It's Going to Be a Bummer Year, Folks
TheStreet.com
Thu, 01/7/16 - 01:02 pm
Tags:
biotech, Celgene, biosimilars, Isis Pharmaceuticals, CAR-T, Bluebird Bio, Puma Biotechnology, MannKind
10 Biotechs Short Sellers Are Betting Against
Yahoo/Benzinga
Wed, 12/30/15 - 10:40 am
Tags:
biotech, Global Blood Therapeutics, Clovis Oncology, Epizyme, Bluebird Bio, Puma Biotechnology, Tokai, MannKind, Myriad Genetics, Orexigan, KaloBios
4 Top Biotech Stocks for 2016
24/7 Wall St
Fri, 12/18/15 - 08:57 am
Tags:
Roche, Amgen, Bluebird Bio, Valeant Pharmaceuticals
5 Key BioPharma Movers That Cannot Be Ignored
24/7 Wall St
Sun, 12/13/15 - 10:57 am
Tags:
IMO-8400, Idera Pharmaceuticals, pracinostat, MEI Pharma, Bluebird Bio, CAR-T, Cara Therapeutics, CR845, TherapeuticsMD, TX-004HR
Bluebird Bio: Another Look At The Company After The 2015 ASH Meeting
Seeking Alpha
Fri, 12/11/15 - 10:28 pm
Tags:
Bluebird Bio
Bluebird Sickle Cell Gene Therapy Falls Short of High Expectations
TheStreet.com
Sun, 12/6/15 - 11:04 am
Tags:
Bluebird Bio, sickle cell disease, gene therapy, LentiGlobin
Bluebird, Celgene See Promise in T Cell Therapy for Multiple Myeloma
TheStreet.com
Sat, 12/5/15 - 12:37 pm
Tags:
Bluebird Bio, Celgene, t cell therapy, Multiple Myeloma

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.